ÂÜÀòÂÒÂ×

Gaston Picchio joined Arbutus from Janssen R&D, bringing with him over thirty years of basic and clinical experience in the field of human virology and sixteen years of industry experience dedicated to the development of antiviral drugs including drug approvals for the treatment of HIV (etravirine and rilpivirine) and HCV (telaprevir and simeprevir). In 2015, Dr. Picchio was a recipient of the Johnson Medal for the development of telaprevir and simeprevir and combinations thereof. Prior to joining Arbutus, Dr. Picchio served in various senior management positions at Janssen R&D, including Vice President of Scientific Innovation Infectious Diseases & Vaccines, Vice President of Hepatitis Disease Area Leader and Vice President of Clinical Virology Infectious Diseases & Vaccines. Dr. Picchio received his master’s degree in molecular biology from University Centro de Altos Estudios en Ciencias Exactas and his Ph.D from University of Buenos Aires.